HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
MONDAY, Sept. 12, 2022 (HealthDay News) -- Frequent blood donors don’t need to worry about iron deficiency harming their health, new research shows.
Even though about 35% of donors can become iron deficient after repeated blood donations, researchers have found that this produces no harmful effects on either the quality of donated blood or the well-being of frequent donors.
“This finding is good news because it not only shows that blood donated by frequent donors remains of high quality, but also that those who donate blood regularly are not being significantly harmed by doing so,” said lead researcher Dr. Eldad Hod. He is an associate professor of pathology and cell biology at Columbia University’s Irving Medical Center in New York City.
Participants donated one standard unit of blood and completed questionnaires about their physical and mental health and quality of life. They also completed brain tests gauging their memory, attentiveness and ability to process information.
Donors then returned six weeks later to repeat the testing. They also were randomly assigned to receive an intravenous infusion of either iron or a placebo (inactive substance).
Four to six months later, participants made a second blood donation and completed another round of testing. They had a final round of testing six weeks later.
The researchers had suspected the donated blood would fail to meet quality standards of the U.S. Food and Drug Administration. They also thought that donors who had an iron infusion would be in better health than those who got a placebo.
While the iron infusion did correct donors’ iron deficiency, which persisted in those who received the placebo, donated blood from both groups continued to meet FDA quality standards.
Further, neither group differed significantly on brain tests and quality-of-life measures, according to a news release from the American Society of Hematology.
The study was published Sept. 6 in the journal Blood.
The American Red Cross has more about blood donation.
SOURCE: American Society of Hematology, news release, Sept. 7, 2022
- More Diverse Pool of Blood Donors Needed to Help Sickle Cell ... ›
- Blood Donation Surge After 9/11 Waned Fast - Consumer Health ... ›
- Teens Can Donate Blood, But May Need Iron Supplements After ... ›
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on September 21, 2022